Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
Worldwide, cancer is the second leading cause of mortality after cardiovascular diseases. Among the numerous malignant tumors in human, digestive system cancers are the primary cause of morbidity and mortality. Acetylation and deacetylation are crucially involved in cancer occurrence and development...
Saved in:
Main Authors: | Bingyi Zhou, Deliang Liu, Yuyong Tan |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/4bba92dba64941db88bd778c548d3f1b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
by: Jacob King, et al.
Published: (2021) -
Epigenetic Repression of Chloride Channel Accessory 2 Transcription in Cardiac Fibroblast: Implication in Cardiac Fibrosis
by: Tinghui Shao, et al.
Published: (2021) -
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
by: Tandon N, et al.
Published: (2016) -
Molecular cloning and subcellular localization of six HDACs and their roles in response to salt and drought stress in kenaf (Hibiscus cannabinus L.)
by: Wei,Fan, et al.
Published: (2019) -
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
by: Peedicayil J
Published: (2020)